{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:37:14Z","timestamp":1787031434059,"version":"build-2736575974"},"reference-count":43,"publisher":"Academy of Medicine, Singapore","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Acad Med Singap"],"published-print":{"date-parts":[[2021,7,29]]},"abstract":"<jats:p>Introduction: Non-cystic fibrosis bronchiectasis (NCFB) is a highly heterogenous disease. We describe the clinical characteristics of NCFB patients and evaluate the performance of Bronchiectasis Severity Index (BSI) in predicting mortality. Methods: Patients attending the bronchiectasis clinic between August 2015 and April 2020 with radiologically proven bronchiectasis on computed tomography were recruited. Clinical characteristics, spirometry, radiology, microbiology and clinical course over a median period of 2.4 years is presented. Results: A total of 168 patients were enrolled in this prospective cohort study. They were predominantly women (67.8%), Chinese (87.5%) and never-smokers (76.9%). Median age of diagnosis was 64 years (interquartile range 56\u201371) and the most common aetiology was \u201cidiopathic\u201d bronchiectasis (44.6%). Thirty-nine percent had normal spirometries. Compared to female patients, there were more smokers among the male patients (53.8% versus 8.5%, P&lt;0.001) and a significantly larger proportion with post-tuberculous bronchiectasis (37.0% vs 15.8%, P=0.002). Fifty-five percent of our cohort had a history of haemoptysis. Lower body mass index, presence of chronic obstructive pulmonary disease, ever-smoker status, modified Reiff score, radiological severity and history of exacerbations were risk factors for mortality. Survival was significantly shorter in patients with severe bronchiectasis (BSI&gt;9) compared to those with mild or moderate disease (BSI&lt;9). The hazard ratio for severe disease (BSI&gt;9) compared to mild disease (BSI 0\u20134) was 14.8 (confidence interval 1.929\u2013114.235, P=0.01). Conclusion: The NCFB cohort in Singapore has unique characteristics with sex differences. Over half the patients had a history of haemoptysis. The BSI score is a useful predictor of mortality in our population. Keywords: Bronchiectasis, exacerbations, gender, haemoptysis, mortality, Reiff score, sex<\/jats:p>","DOI":"10.47102\/annals-acadmedsg.202178","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T07:03:45Z","timestamp":1627455825000},"page":"556-565","source":"Crossref","is-referenced-by-count":8,"title":["Heterogeneity of non-cystic-fibrosis bronchiectasis in multiethnic Singapore: A prospective cohort study at a tertiary pulmonology centre"],"prefix":"10.47102","volume":"50","author":[{"given":"Si Ling","family":"Young","sequence":"first","affiliation":[{"name":"Singapore General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youxin","family":"Puan","sequence":"additional","affiliation":[{"name":"Singapore General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Yuan","family":"Chew","sequence":"additional","affiliation":[{"name":"Singapore General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haja Mohideen Salahudeen","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Singapore General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei Yee","family":"Tiew","sequence":"additional","affiliation":[{"name":"Singapore General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan Liang","family":"Tan","sequence":"additional","affiliation":[{"name":"Sengkang General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko Siyue","family":"Koh","sequence":"additional","affiliation":[{"name":"Singapore General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken Cheah Hooi","family":"Lee","sequence":"additional","affiliation":[{"name":"Singapore General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"26165","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Chalmers JD, Chang AB, Chotirmall SH, et al. Bronchiectasis. Nat Rev Dis Prim 2018;4:45.","DOI":"10.1038\/s41572-018-0042-3"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Quint JK, Millett ERC, Joshi M, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: A population-based cohort study. Eur Respir J 2016;47:186-93.","DOI":"10.1183\/13993003.01033-2015"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Henkle E, Chan B, Curtis JR, et al. Characteristics and Health-care Utilization History of Patients With Bronchiectasis in US Medicare Enrollees With Prescription Drug Plans, 2006 to 2014. Chest 2018;154:1311-20.","DOI":"10.1016\/j.chest.2018.07.014"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Ringshausen FC, Rademacher J, Pink I, et al. Increasing bronchiectasis prevalence in Germany, 2009-2017: A population-based cohort study. Eur Respir J 2019;54:2009-17.","DOI":"10.1183\/13993003.00499-2019"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Aliberti S, Sotgiu G, Lapi F, et al. Prevalence and incidence of bronchiectasis in Italy. BMC Pulm Med 2020;20:1-6.","DOI":"10.1186\/s12890-020-1050-0"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Lin JL, Xu JF, Qu JM. Bronchiectasis in China. Ann Am Thorac Soc 2016;13:609-16.","DOI":"10.1513\/AnnalsATS.201511-740PS"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Choi H, Yang B, Nam H, et al. Population-based prevalence of bronchiectasis and associated comorbidities in South Korea. Eur Respir J 2019;54.","DOI":"10.1183\/13993003.00194-2019"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Yang B, Jang HJ, Chung SJ, et al. Factors associated with bronchiectasis in Korea: a national database study. Ann Transl Med 2020;8:1350.","DOI":"10.21037\/atm-20-4873"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Chandrasekaran R, Mac Aog\u00e1in M, Chalmers JD, et al. Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis. BMC Pulm Med 2018;18:1-14.","DOI":"10.1186\/s12890-018-0638-0"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Aksamit TR, O\u2019Donnell AE, Barker A, et al. Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry. Chest 2017;151:982-92.","DOI":"10.1016\/j.chest.2016.10.055"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Palwatwichai A, Chaoprasong C, Vattanathum A, et al. Clinical, laboratory findings and microbiologic characterization of bronchiectasis in Thai patients. Respirology 2002;7:63-6.","DOI":"10.1046\/j.1440-1843.2002.00367.x"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Park J, Kim S, Lee YJ, et al. Factors associated with radiologic progression of non-cystic fibrosis bronchiectasis during long-term follow-up. Respirology 2016;21:1049-54.","DOI":"10.1111\/resp.12768"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Visser SK, Bye PTP, Fox GJ, et al. Australian adults with bronchiectasis: The first report from the Australian Bronchiectasis Registry. Respir Med 2019;155:97-103.","DOI":"10.1016\/j.rmed.2019.07.016"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Dhar R, Singh S, Talwar D, et al. Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry. Lancet Glob Heal 2019;7:e1269-79.","DOI":"10.4103\/0970-258x.310987"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Olveira C, Padilla A, Mart\u00ednez-Garc\u00eda M-\u00c1, et al. Etiology of Bronchiectasis in a Cohort of 2047 Patients. An Analysis of the Spanish Historical Bronchiectasis Registry. Arch Bronconeumol (English Ed.) 2017;53:366-74.","DOI":"10.1016\/j.arbr.2017.05.005"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Sharif N, Baig MS, Sharif S, et al. Etiology, Clinical, Radiological, and Microbiological Profile of Patients with Non-cystic Fibrosis Bronchiectasis at a Tertiary Care Hospital of Pakistan. Cureus 2020;12:e7208.","DOI":"10.7759\/cureus.7208"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Lee H, Choi H, Sim YS, et al. KMBARC registry: protocol for a multicentre observational cohort study on non-cystic fibrosis bronchiectasis in Korea. BMJ Open 2020;10:1-8.","DOI":"10.1136\/bmjopen-2019-034090"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Chalmers JD, Aliberti S, Filonenko A, et al. Characterization of the \u201cfrequent exacerbator phenotype\u201d in bronchiectasis. Am J Respir Crit Care Med 2018;197:1410-20.","DOI":"10.1164\/rccm.201711-2202oc"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Hill AT, Sullivan AL, Chalmers JD, et al. British thoracic society guideline for bronchiectasis in adults. Thorax 2019;74.","DOI":"10.1136\/thoraxjnl-2018-212463"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 2017;50.","DOI":"10.1183\/13993003.00629-2017"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38.","DOI":"10.1183\/09031936.05.00034805"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Reiff DB, Wells AU, Carr DH, et al. CT findings in bronchiectasis: Limited value in distinguishing between idiopathic and specific types. Am J Roentgenol 1995;165:261-7.","DOI":"10.2214\/ajr.165.2.7618537"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiectasis severity index an international derivation and validation study. Am J Respir Crit Care Med 2014;189:576-85.","DOI":"10.1164\/rccm.201309-1575oc"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Hill AT, Haworth CS, Aliberti S, et al. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J 2017;49: 1700051.","DOI":"10.1183\/13993003.00051-2017"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Guan WJ, Chen RC, Zhong NS. The bronchiectasis severity index and FACED score for bronchiectasis. Eur Respir J 2016;47:382-84.","DOI":"10.1183\/13993003.01717-2015"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"McShane PJ, Naureckas ET, Strek ME. Bronchiectasis in a diverse US population: Effects of ethnicity on etiology and sputum culture. Chest 2012;142:159-67.","DOI":"10.1378\/chest.11-1024"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Vidaillac C, Yong VFL, Jaggi TK, et al. Gender differences in bronchiectasis: A real issue? Breathe 2018;14:108-21.","DOI":"10.1183\/20734735.000218"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Horton KC, MacPherson P, Houben RMGJ, et al. Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. PLoS Med 2016;13: e1002119.","DOI":"10.1371\/journal.pmed.1002119"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Dhanaraj B, Papanna MK, Adinarayanan S, et al. Prevalence and risk factors for adult pulmonary tuberculosis in a metropolitan city of South India. PLoS One 2015;10: e0124260.","DOI":"10.1371\/journal.pone.0124260"},{"key":"ref29","unstructured":"Central TB Division. Revised National Tuberculosis Control Programme Annual Status Report. India TB Report 2018, March 2018. Available at: https:\/\/tbcindia.gov.in\/showfile.php?lid=3314. Accessed on 28 May 2021."},{"key":"ref30","unstructured":"World Health Organization. WHO: Tuberculosis Country Profiles 2018. Available at: https:\/\/www.who.int\/tb\/publications\/global_report\/ tb19_Report_country_profiles_15October2019.pdf?ua=1. Accessed on 28 May 2021."},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Jappar SB, Low SY. Tuberculosis trends over a five-year period at a tertiary care university-affiliated hospital in Singapore. Singapore Med J 2015;56:502-5.","DOI":"10.11622\/smedj.2015134"},{"key":"ref32","unstructured":"Stretton R, Poppelwell L, Salih W, et al. Patterns of spirometry in bronchiectasis patients and relationship to markers of disease severity and hospitalisation. Eur Respir J 2013;42:P2695."},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Chalmers JD, Aliberti S, Blasi F. Management of bronchiectasis in adults. Eur Respir J 2015;45:1446-62.","DOI":"10.1183\/09031936.00119114"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Finch S, McDonnell MJ, Abo-Leyah H, et al. A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis. Ann Am Thorac Soc 2015; 12:1602-11.","DOI":"10.1513\/AnnalsATS.201506-333OC"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"King PT, Holdsworth SR, Freezer NJ, et al. Microbiologic follow-up study in adult bronchiectasis. Respir Med 2007;101:1633-8.","DOI":"10.1016\/j.rmed.2007.03.009"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Davies G, Wells AU, Doffman S, et al. The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Eur Respir J 2006;28:974-9.","DOI":"10.1183\/09031936.06.00074605"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Serisier DJ, Martin ML, Mcguckin MA, et al. Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis. JAMA 2013; 309:1260-7.","DOI":"10.1001\/jama.2013.2290"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Martin LN, Higgins L, Mohabir P, et al. Bronchial Artery Embolization for Hemoptysis in Cystic Fibrosis Patients: A 17-Year Review. J Vasc Interv Radiol 2020;31:331-5.","DOI":"10.1016\/j.jvir.2019.08.028"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Dave BR, Sharma A, Kalva SP, et al. Nine-year single-center experience with transcatheter arterial embolization for hemoptysis: medium-term outcomes. Vasc Endovascular Surg 2011;45:258-68.","DOI":"10.1177\/1538574410395036"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Jang EJ, Lee C-H, Yoon H Il, et al. Association between inhaler use and risk of haemoptysis in patients with non-cystic fibrosis bronchiectasis. Respirology 2015;20:1213-21.","DOI":"10.1111\/resp.12618"},{"key":"ref41","unstructured":"Guan WJ, Yuan JJ, Gao YH, et al. Hemoptysis in adults with bronchiectasis: correlation with disease severity and exacerbation risk. Zhonghua Jie He He Hu Xi Za Zhi 2017;40:16-23."},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Ellis HC, Cowman S, Fernandes M, et al. Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: A 19-year cohort study. Eur Respir J 2016;47:482-9.","DOI":"10.1183\/13993003.01312-2015"}],"container-title":["Annals of the Academy of Medicine, Singapore"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T13:58:14Z","timestamp":1672927094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.annals.edu.sg\/pdf\/50VolNo7Jul2021\/V50N7p556.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,29]]},"published-print":{"date-parts":[[2021,7,29]]}},"URL":"https:\/\/doi.org\/10.47102\/annals-acadmedsg.202178","relation":{},"ISSN":["0304-4602"],"issn-type":[{"value":"0304-4602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,29]]}}}